Strong Bioprocessing Growth
Bioprocessing delivered high single-digit organic growth in Q4, marking the fourth consecutive quarter of outperformance. The segment showed strong order intake and is expected to grow mid-to-high single digits in 2025.
Record Free Cash Flow
Avantor generated $222 million in free cash flow in Q4 and $768 million for the year, achieving more than 110% free cash flow conversion for the full year.
Successful Debt Reduction
Avantor reduced its net leverage to 3.2 times by paying down $1.3 billion of debt in 2024, down from nearly 4 times at the start of the year.
Innovation and New Product Launches
Avantor launched new services and products, including a virtual assistant for laboratory researchers and Masterflex Miniflex Panel-Mount pumps, contributing to an expanded portfolio.
Adjusted EBITDA Margin Expansion
The adjusted EBITDA margin expanded to 18.2% in Q4, the highest level in more than a year, driven by improved mix and cost transformation initiatives.